Expression and carbonylation of creatine kinase in the quadriceps femoris muscles of patients with chronic obstructive pulmonary disease.
about
Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findingsProtein carbonylation and muscle function in COPD and other conditions.An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patientsProteomic identification of carbonylated proteins and their oxidation sitesRedox proteomics identification of oxidatively modified myocardial proteins in human heart failure: implications for protein function.Exercise training prevents TNF-α induced loss of force in the diaphragm of miceSystemic inflammatory profile and response to anti-tumor necrosis factor therapy in chronic obstructive pulmonary disease.Protein carbonylation and metabolic control systems.Oxidative stress in the external intercostal muscles of patients with obstructive sleep apnoeaEpigenetic regulation of muscle phenotype and adaptation: a potential role in COPD muscle dysfunction.Critical role of aldehydes in cigarette smoke-induced acute airway inflammation.Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease.Proteomics-based diagnosis of chronic obstructive pulmonary disease: the hunt for new markers.Role of Protein Carbonylation in Skeletal Muscle Mass Loss Associated with Chronic ConditionsMolecular changes in smoking-related lung cancer.Respiratory diseases and muscle dysfunction.Metabolic derangements in COPD muscle dysfunction.Protein carbonylation: proteomics, specificity and relevance to aging.Enhanced expression of proteins involved in energy production and transfer in breast muscle of pedigree male broilers exhibiting high feed efficiency.Phenotypic and metabolic features of mouse diaphragm and gastrocnemius muscles in chronic lung carcinogenesis: influence of underlying emphysema.The mitochondrial phenotype of peripheral muscle in chronic obstructive pulmonary disease: disuse or dysfunction?Cigarette smoke-induced oxidative stress: A role in chronic obstructive pulmonary disease skeletal muscle dysfunction.Organization of metabolic pathways in vastus lateralis of patients with chronic obstructive pulmonary disease.Formoterol attenuates increased oxidative stress and myosin protein loss in respiratory and limb muscles of cancer cachectic rats.Sex differences in function and structure of the quadriceps muscle in chronic obstructive pulmonary disease patients.Network modules uncover mechanisms of skeletal muscle dysfunction in COPD patients.Insulin treatment reverses the increase in atrogin-1 expression in atrophied skeletal muscles of diabetic rats with acute joint inflammation.Biological Activities, Health Benefits, and Therapeutic Properties of Avenanthramides: From Skin Protection to Prevention and Treatment of Cerebrovascular DiseasesAbnormal Transition Pore Kinetics and Cytochrome C Release in Muscle Mitochondria of Patients with Chronic Obstructive Pulmonary Disease
P2860
Q26775701-C24EAB94-2581-46D0-9D97-B75F3BBDF850Q30354982-BF7C57E3-83A6-4B11-93BB-6B39810CE582Q33901722-66BB7B46-81C0-43F5-8747-82A5C817FA70Q34061404-66AADA9C-8414-48F9-BEB4-07203021BCB4Q34118916-D5C41553-22E0-47CE-8C71-ADF7AE072CC1Q34273494-B06232B0-1FF1-4466-BF85-6B657968976BQ34542081-55E9FDCD-DBFA-477E-9943-A052CD2AB0B7Q35779864-8B023423-32C1-4D3B-B7CB-F3692010DC35Q36129390-CEA24C75-8DF7-4852-A61F-A207F837FF71Q36169178-C9300834-D0D1-4492-B810-C2CF10C20A92Q36850787-094F3357-2764-4C52-B00E-85063A4DA3F5Q36901033-594136AF-578E-43C6-B2C4-5EEE33C3C33AQ37115925-5D7E7075-6776-413E-8926-819899B4DFDDQ37304126-25EEED8A-1A55-49BA-9E31-A77163F90D9CQ37566391-B7749A84-7746-4384-8C32-2E1C5AD85FB4Q37963519-0248EE0C-4076-4118-9A95-E5728A2B8201Q37979250-FC253555-7E95-42CB-A84C-3D49F07A5F48Q38071563-8220D9FC-845A-45C2-BB04-3D677C1D7E7CQ38151609-B1498EEB-335D-46B5-847D-D99D38C90FB1Q38776919-7AA2AD81-D958-4197-96EF-1B748324C5B7Q41407774-03B04964-0B43-4CB0-A123-321468C048EBQ42440941-1D3595D8-E64A-43BB-99AE-53EC88EB90E8Q43088310-5C7AFCCE-EB50-4FB0-B4D7-14EC81BCE8E0Q46477819-6F9C583F-0456-4A52-BA08-8BDF8FCD9446Q47130400-0CAD47EB-90BC-4FF7-9869-3D9348CBF3BDQ47149227-25F4468A-D3D8-4AE6-B292-F02944CFBE96Q49795543-27473C0A-D0ED-4232-BD8B-BFC1D7FD8C69Q54982592-EFDC1F87-0D4C-4EDB-B895-9233F5AC5757Q58711702-56DCD851-387F-48FC-94FD-F1DD806A88C4Q58840482-B9C3C572-35C2-4DE2-87E4-34F53FDDE456
P2860
Expression and carbonylation of creatine kinase in the quadriceps femoris muscles of patients with chronic obstructive pulmonary disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Expression and carbonylation o ...... obstructive pulmonary disease.
@en
Expression and carbonylation o ...... obstructive pulmonary disease.
@nl
type
label
Expression and carbonylation o ...... obstructive pulmonary disease.
@en
Expression and carbonylation o ...... obstructive pulmonary disease.
@nl
prefLabel
Expression and carbonylation o ...... obstructive pulmonary disease.
@en
Expression and carbonylation o ...... obstructive pulmonary disease.
@nl
P2093
P2860
P356
P1476
Expression and carbonylation o ...... obstructive pulmonary disease.
@en
P2093
Esther Barreiro
Ghassan Matar
Joaquim Gea
Sabah N A Hussain
P2860
P304
P356
10.1165/RCMB.2005-0114OC
P577
2005-09-15T00:00:00Z